Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: sCD163 in HELLP Syndrome

View source ↗

Summary

A clinical trial investigating soluble CD163 (sCD163) in HELLP syndrome during pregnancy is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: HELLP Syndrome Complicating Pregnancy | Status: NOT_YET_RECRUITING